References

  • Abeloff, M. D., Armitage, J. O., Lichter, A. S., & Niederhuber, J. E.    
    (Eds.). (2000). Clinical Oncology (2nd ed.). New York: Churchill Livingstone.
  • Ahles, T., Saykin, A., Furstenberg, C., & et.al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
  • Albright, A., & Valente, S. (1998). Depression and suicide. In R. Carroll-Johnson, et. al. (Ed.), Psychosocial nursing care along the cancer continuum (pp. 153-165). Pittsburgh, PA: Oncology Nursing Press.
  • American Cancer Society: Sexuality and cancer for the woman who has cancer and her partner. (2001) Publication #4657.
  • American Cancer Society: Sexuality and cancer for the man who has cancer and his partner. (2001) Publication #4658.
  • Berg, D. (2001). Diarrhea. In J. M. Yasko (Ed.), Nursing Management of Symptoms Associated with Chemotherapy (5th ed., pp. 109-130). West Conshohocken, PA: Menicus Health Care Communication.
  • Boyle, D. (2001). Psychosocial issues. In E. Lin (Ed.), Advanced practice in oncology nursing (pp. 213-232). Philadelphia: WB Saunders.
  • Brietbart, W. (2002). Depression. In K. Kuebler & P. Esper (Eds.), Palliative practice from a-z (pp. 85-88). Pittsburgh, PA: Oncology Nursing Press Press.
  • Briscoe, K. (1989). Optimal management of nausea and vomiting in clinical oncology. Oncology, 3(8 Supplement), 11-15.
  • Carroll-Johnson, R. M., Gorman, L. M., & Bush, N. J. (Eds.). (1998). Anxiety and the cancer experience. Pittsburgh, PA: Oncology Nursing Press.
  • The Cleveland Clinic Foundation. For your information: home instructions for management of nausea. (1995).
  • Conrad KJ. (2001). Cutaneous reactions. In Yasko JM (Ed.), Nursing Management of Symptoms Associated with Chemotherapy (5th ed.).
  • Constipation protocol. (1995). Cleveland Clinic Foundation: Triage protocols for the oncology nurse help line program.
  • Cope, D. (2001). Exploring the relationship between cognitive function and chemotherapy. Clinical Journal of Oncology Nursing, 5(5), 233-234.
  • Costabel, U., & King, T. E. (2001). International consensus statement on idiopathic pulmonary fibrosis. European Respiratory Journal, 17(2), 163-167.
  • Couillard-Getreuer DL, & Lutgen Heery M. (1994). Protective mechanisms: skin. In Gross J & Libey Johnson B (Eds.), Handbook of Oncology Nursing (2nd ed., pp. 421-463). Boston, MA: Jones & Bartlett.
  • Fabian, C. J., Molina, R., & Slavik, M. (1990). Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Investigational New Drugs, 8(1), 57-63.
  • Health Information. (2002). Retrieved May 9, 2003, from http://www.nei.nih.gov/health/.
  • Gacsedi, R. A. (2002). Massage therapy for patients with cancer. Clinical Journal of Oncology Nursing, 6(1), 52-54.
  • Gordon, K. B., Tajuddin, A., & Guitart, J. (1995). Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer, 75(8), 2169-2173.
  • Gross, J., & Johnson, B. L. (Eds.). (1998). Handbook of oncology nursing. London: Jones and Bartlett Publishers International Publications.
  • Harsch, R. (2002). Preventing infection during your chemotherapy treatment. Georgia-Pacific health smart institute association for professionals in infection control and epidemiology.
  • Hoffman, R., Benz, E. J., Shattil, S. J., Furie, B., Cohen, H. J., Silberstein, L. E., et al. (Eds.). (2000). Hematology: basic principles and practice, 3rd edition. New York: Churchill Livingstone.
  • Hussein MA, Wood L, Saluan MA, & et al. (1998). Efficacy of pyridoxine to ameliorate cutaneous toxicity associated with doxil abstract # 4143. Paper presented at the American Society of Hematology.
  • ImmuCyst® product information. (2002). Retrieved May 8, 2003, from http://www.immucyst.com/product.html
  • Itano, J., & Taoka, K. (Eds.). (1998). Core curriculum for oncology nursing (3rd ed.). Philadelphia PA: W.B Saunders Co.
  • Karlowicz, K. (Ed.). (1995). Urologic nursing; principles and practice. Philadelphia, PA: WB Saunders Co.
  • King, T. E., et. al. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). American Journal of respiratory critical care medicine, 161(2), 646-664.
  • Lee A, & Thomson J. (1999). Drug-induced skin reactions. Pharmaceutical Journal, 262, 357-362.
  • Lexi-Drugs online. (2002, 3/18/03). Retrieved May 5, 2003, from http://www.crlonline.com
  • Living with glaucoma. (2002). Retrieved May 9, 2003, from http://www.glaucoma.org/
  • Lubejko, B. G., & Sartorius, S. E. (1993). Nursing considerations in paclitaxel (Taxol®) administration. Seminars in Oncology, 20(4, Supplement 3), 26-30.
  • Lynch, M. P. (2000). Depression in the cancer patient. Nurse Practioner SIG(Nov), 4-5.
  • Malpas, J., Bergsagel, D., & Kyle, A. (Eds.). (1998). Myeloma biology and management (2nd ed.). New York: Oxford university press.
  • MD Consult: A resource for clinicians. (2003, 1/2/2003). Retrieved May 8, 2003, from http://home.mdconsult.com
  • Meek, P. M., et. al. (1999). Dyspnea. Mechanisms, assessment and management: a consensus statement. American Thoracic Society. American Journal of respiratory critical care medicine, 159(1), 321-340.
  • Mellors, R. C. (8/27/2002). Immunopathology; hypersensitivity reactions. Retrieved May 8, 2003, from http://www.med.cornell.edu/education.
  • Merideth, P. V., & Horan, N. M. (Eds.). (2000). Adult primary care. Philadelphia: WB Saunders Co.
  • Mortimer J, & Anderson I. (1990). Weekly fluorouracil and high-dose leucovorin: efficacy and treatment of cutaneous toxicity. Cancer Chemotherapy and Pharmacology, 26, 449-452.
  • Mosby's GenRx. (2001, 1/2/2003). Retrieved May 8, 2003, from http://home.mdconsult.com
  • Our bodies, ourselves for the new century: A book by and for women  (Comprehensive book on women's health and sexuality) Boston Women's Health Book Collective. (1998). New York: Touchstone Books.
  • PEG-INTRON®
    (peginterferon alfa-2b) Powder for Injection. (2002). Retrieved May 9, 2003, from http://www.pegintron.com/
  • Pike, K. (2001). Hand-foot syndrome. Oncology Nursing Forum, 28(10), 1519-1520.
  • Pisarnthanarax, N., & Duvic M. (2002). Dermatologic complications of cancer chemotherapy. In JF Holland & E. Frei (Eds.), Cancer Medicine (pp. 2271-2278). Hamilton, Ontario: BC Decker Inc.
  • PM Meek, & et. al. (1999). Dyspnea: mechanisms, assessment and management: a consensus statement American Thoracic Society. American Journal of Respiratory Critical Care Medicine, 159(1), 321-340.
  • Preparing for your treatment with BEXXAR® : A patient's guide to the BEXXAR® therapeutic regimen for non-Hodgkin's lymphoma, Patient resource pamphlet. (2003).  The GlaxoSmithKline Group of Companies and Corixa Corporation.
  • Questions and Answers About Taxotere®for Injection Concentrate. (2002). Retrieved May 9, 2003, from http://www.aventis-us.com.
  • Recommendations for the use of antiemetics. (2002, 2002). Retrieved May 9, 2003, from http://www.asco.org/ac/1,1003,_12-002032-00_18-0010772-00_19-0010774-00_20-001,00.asp
  • Seller, R. (Ed.). (2000). Differential diagnosis of common complaints. Philadelphia: WB Saunders Co.
  • Schover, L. R. (1997). Sexuality and fertility after cancer. New York: John Wiley & Sons.
  • Schwartz, S., & Plawecki, H. (2002). Consequences of chemotherapy on the sexuality of patients with lung cancer. Clinical Journal of Oncology Nursing, 6(4).
  • Self Help for Hard of Hearing People. (2002, 4/11/03). Retrieved May 9, 2003, from http://www.shhh.org
  • Shelton, B. K., & Turnbough, L. (1996). Flu-like syndrome. In S. Groenwald (Ed.), Cancer Symptom Management (pp. 59-71). Boston, MA: Jones and Bartlett.
  • Sherry VW. (2001). Taste alterations among patients with cancer. Clinical Journal of Oncology Nursing, 6(2), 73-77.
  • Skeel, R. (Ed.). (1999). Handbook of cancer chemotherapy. Philadelphia: Lippincott, Williams & Wilkins.
  • Specific Information for the Health Professional. (2003, May 7, 2003). Retrieved May 8, 2003, from http://www.atsdr.cdc.gov
  • Spencer, P. (2002). Anxiety. In K. Kuebler & P. Esper (Eds.), Palliative practice from a - z (pp. 23-26). Pittsburgh, PA: ONS Press.
  • St Marie, B. (2000). Anxiety. In D. H. Camp-Sorrell, R, (Ed.), Clinical manual for the oncology practice nurse (pp. 133-134). Pittsburgh, PA: ONS Press.
  • Stoller, J. K., Ahmad, M., & Longworth, D. L. (Eds.). (2002). Intensive review of internal medicine (3rd ed.). Philadelphia PA: Lippincott, Williams and Wilkins.
  • Tierney, L. M., McPhee, S. J., & Papadakis, M. A. (Eds.). (2001). Current medical diagnosis and treatment (40th ed.). Stanford, CT: Appleton and Lange.
  • Triozzi, P., & Laszlo, J. (1990). Recent advances in the control of nausea and vomiting. Primary Care & Cancer.
  • Uphold, C. R., & Graham, M. V. (Eds.). (1999). Clinical guidelines in adult health (5th ed.). Gainesville FL: Barmarrae Books.
  • USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. (1995). MMWR, 44, RR-8.
  • Uthman, E. O. (1996, 9/16/2001). Interpretation of lab test profiles. Retrieved May 8, 2003, from http://mededucation.bjmu.edu.cn.
  • Viale, P., & Mister, S. (2001). Utilization of medical-assistance programs for medically uninsured patients: one public teaching hospital's experience. Clinical Journal of Oncology Nursing, 5(6), 247-252.
  • Voss, M. A. B., & Wilkes, G. M. (1999). Neurotoxicities. American Journal of Nursing, Oncology Nursing Update, 20-23.
  • Weihofen, D., & Marino, C. (1998). The cancer survival cookbook. New York: John Wiley & Sons.
  • Weiss PA, & O'Rourke M. (1999). Cutaneous manifestations of cancer and cancer treatment. American Journal of Nursing (April Supplement), 13-16.
  • Wilkes, G. M. (1996). Neurological disturbances. In S. Groenwald (Ed.), Cancer Symptom Management (pp. 323-330). Boston, MA: Jones and Bartlett.
  • Wilkes, G. M., Ingwersen, & Barton-Burke (Eds.). (2002). Oncology Nursing Drug Handbook. Boston, MA: Jones and Bartlett.
  • Wilkinson, K. (2001). Irinotecan hydrochloride. Clinical Journal of Oncology Nursing, 5(4), 179.
  • Woodruff, R. (1997). Gastrointestinal. In Pharmacia & Upjohn (Eds.), Symptom control in advanced cancer (pp. 18-21). Melbourne.
  • Yarbro, C. H., Frogge, M. H., Goodman, M., & Groenwald, S. L. (Eds.). (1999). Cancer symptom management (5th ed.). Boston, MA: Jones and Barlett.
  • Zilbergeld, B. (1999). The new male sexuality: The truth about men, sex and pleasure. New York: Bantam Books.

Clinical Trials

Search Cancer Clinical Trials

Carefully controlled studies to research the safety and benefits of new drugs and therapies.

Search

Peer Support

4th Angel Mentoring Program

Connect with a 4th Angel Mentor and speak to someone who understands.

4thangel.ccf.org

ChemoCare

Social Links